POTENTIAL ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS IN SUBSTANCE USE DISORDER: A SYSTEMATIC REVIEW OF RANDOMIZED TRIALS
Glucagon-like peptide type 1 receptor agonistsIncretin effect and systemic effects of glucagon-like peptide type 1 and its agonists The incretin effect describes the phenomenon whereby oral glucose elicits higher (23 times) insulin secretory responses than does intravenous glucose.25 This is due to incretin hormones, such as GLP-1 or glucose-dependent insulinotropic polypeptide, which stimulate insulin secretion in response to food intake
Insulin Resistance: When a provider prescribes GLP-1 to treat insulin resistance or related metabolic issues, it may qualify for HSA and FSA coverage
Verify at checkout that your specific tier bundles consultation, medication, and shipping into the stated monthly price without add-ons
In integrative psychiatry settings, naltrexone is used alongside mindfulness, nutritional therapy, and trauma-informed psychotherapy to support the whole person mind, body, and neurochemistry
